johnson fistel.jpg
RYZB News: Johnson Fistel Investigates Proposed Sale of RayzeBio; Is $62.50 a Fair Price?
26 déc. 2023 09h23 HE | Johnson Fistel, LLP
On December 26, 2023, RayzeBio announced that it had entered a deal with Bristol Myers Squibb.
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
30 mai 2023 08h03 HE | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20.7 Million
15 déc. 2020 08h05 HE | Idera Pharmaceuticals, Inc.
EXTON, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the closing of a second tranche under its April 7, 2020, securities purchase agreement (the...